Song, In-Ho <br/><br/>
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jul 2012 
 - 1212-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2011-201010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--therapeutic use<br/>Drug Substitution<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recurrence<br/>Remission Induction<br/>Spine--pathology<br/>Spondylitis, Ankylosing--drug therapy<br/>Sulfasalazine--therapeutic use<br/>Time Factors